Hepavac-101 first-in-man clinical trial of a multi-peptide-based vaccine for hepatocellular carcinoma

被引：0

作者：

Mayer, Andrea ^{[1
]}

Loeffler, Markus ^{[2
]}

Missel, Sarah ^{[1
]}

Accolla, Roberto ^{[3
]}

Ma, Yuk Ting ^{[4
]}

Chaumette, Tanguy ^{[5
]}

Heidenreich, Regina ^{[6
]}

Koenigsrainer, Alfred ^{[7
]}

Ludwig, Joerg ^{[1
]}

Alcoba, Diego ^{[1
]}

Schuster, Heiko ^{[1
]}

Gouttefangeas, Cecile ^{[2
]}

Forlani, Greta ^{[3
]}

Tagliamonte, Maria ^{[8
]}

Ascierto, Paolo Antonio ^{[9
]}

Avallone, Antonio ^{[10
]}

Borrelli, Marco ^{[8
]}

Rammensee, Hans-Georg ^{[2
]}

Sangro, Bruno ^{[11
]}

Inarrairaegui, Mercedes ^{[11
]}

Francque, Sven ^{[12
]}

Vonghia, Luisa ^{[12
]}

Gori, Stefania ^{[13
]}

Weinschenk, Tony ^{[14
]}

Reinhardt, Carsten ^{[1
]}

Gnad-Vogt, Ulrike ^{[6
]}

Singh, Harpreet ^{[14
]}

Buonaguro, Luigi ^{[8
]}

机构：

[1] Immat Biotechnol GmbH, Tubingen, Germany

[2] Eberhard Karls Univ Tubingen, Dept Immunol, Tubingen, Germany

[3] Univ Insubria, Med & Surg, Varese, Italy

[4] Univ Birmingham, Sch Immun & Infect, Birmingham, W Midlands, England

[5] Univ Nantes, Nantes, France

[6] CureVac, Tubingen, Germany

[7] Eberhard Karls Univ Tubingen, Dept Gen Visceral & Transplant Surg, Tubingen, Germany

[8] Ist Nazl Tumori IRCCS Fdn G Pascale, Canc Expt Dept, Canc Immunoregulat Unit, Naples, Italy

[9] Ist Nazl Tumori IRCCS Fdn G Pascale, Melanoma Canc Immunotherapy & Dev Therapeut Uni, Naples, Italy

[10] Ist Nazl Tumori IRCCS Fdn G Pascale, GI Oncol, Naples, Italy

[11] Clin Univ Navarra, Liver Unit, Pamplona, Spain

[12] Univ Hosp Antwerp, Div Gastroenterol & Hepatol, Edegem, Belgium

[13] Osped Sacro Cuore Don G Calabria, Negrar, Italy

[14] Immat US, Houston, TX USA

来源：

JOURNAL OF HEPATOLOGY | 2020年 / 73卷

关键词：

D O I：

暂无

中图分类号：

R57 [消化系及腹部疾病];

学科分类号：

摘要：

FRI339

引用

页码：S566 / S566

页数：1

共 27 条

[1] Hepavac-101 first-in-man clinical trial of a multi-peptide-based vaccine for hepatocellular carcinoma
Buonaguro, Luigi
Mayer, Andrea
Loeffler, Markus
Missel, Sarah
Accolla, Roberto
Ting, Yuk
Chaumette, Tanguy
Heidenreich, Regina
Koenigsrainer, Alfred
Ludwig, Joerg
Alcoba, Diego
Schuster, Heiko
Gouttenfangeas, Cecile
Forlani, Greta
Tagliamonte, Maria
Ascierto, Paolo A.
Avallone, Antonio
Borrelli, Marco
Rammensee, Hans-Georg
Sangro, Bruno
Inarrairaegui, Mercedes
Francque, Sven
Vonghia, Luisa
Gori, Stefania
Weinschenk, Tony
Reinhardt, Carsten
Gnad-Vogt, Ulrike
Singh, Harpreet
CANCER RESEARCH, 2020, 80 (16)
[2] Discovery to first-in-man studies of a multi-peptide-based hepatocellular carcinoma vaccine - HEPAVAC
Buonaguro, Luigi
JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES, 2018, 77 : 37 - 37
[3] HepaVac-101 first-in-man therapeutic cancer vaccine phase I/II clinical trial for hepatocellular carcinoma patients.
Buonaguro, Luigi
Mayer-Mokler, Andrea
Accolla, Roberto
Ma, Yuk Ting
Heidenreich, Regina
Avallone, Antonio
Simeone, Ester
Koenigsrainer, Alfred
Loeffler, Markus
Gouttefangeas, Cecile
Flohr, Christian
Ludwig, Joerg
Rammensee, Hans-Georg
Inarrairaegui, Mercedes
Francque, Sven
Chaumette, Tanguy
Weinschenk, Toni
Reinhardt, Carsten
Gnad-Vogt, Senta Ulrike
Singh, Harpreet
JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (15)
[4] Discovery to first-in-man of a multi-peptide-based hepatocellular carcinoma vaccine adjuvanted with CV8102 (RNAdjuvant) - HEPAVAC
Buonaguro, Luigi
JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES, 2017, 74 : 69 - 69
[5] Discovery to first-in-man studies of a multi-peptide-based hepatocellular carcinoma vaccine adjuvanted with CV8102 (RNAdjuvant) - HEPAVAC
Mayer, A.
Accolla, R.
Ma, Y. T.
Heidenreich, R.
Koenigsrainer, A.
Izzo, F.
Loeffler, M.
Flohr, C.
Mueller, P.
Kutscher, S.
Rammensee, H. -G.
Sangro, B.
Francque, S.
Valmori, D.
Weinschenk, T.
Reinhardt, C.
Gnad-Vogt, U.
Singh-Jasuja, H.
Buonaguro, L.
JOURNAL OF HEPATOLOGY, 2017, 66 (01) : S445 - S446
[6] Discovery to first-in-man studies of a multi-peptide-based hepatocellular carcinoma vaccine adjuvanted with CV8102 (RNAdjuvant®): HEPAVAC
Mayer-Mokler, Andrea
Accolla, Roberto
Ma, Yuk T.
Heidenreich, Regina
Izzo, Francesco
Koenigsrainer, Alfred
Loeffler, Markus
Flohr, Christian
Mueller, Phillip
Kutscher, Sarah
Rammensee, Hans-Georg
Sangro, Bruno
Francque, Sven
Valmori, Danila
Weinschenk, Toni
Reinhardt, Carsten
Gnad-Vogt, Ulrike
Singh, Harpreet
Buonaguro, Luigi
CANCER IMMUNOLOGY RESEARCH, 2016, 4 (11)
[7] Phase I/II Multicenter Trial of a Novel Therapeutic Cancer Vaccine, HepaVac-101, for Hepatocellular Carcinoma
Loffler, Markus W.
Gori, Stefania
Izzo, Francesco
Mayer-Mokler, Andrea
Ascierto, Paolo A.
Koenigsrainer, Alfred
Ma, Yuk Ting
Sangro, Bruno
Francque, Sven
Vonghia, Luisa
Inno, Alessandro
Avallone, Antonio
Ludwig, Jorg
Alcoba, Diego Duarte
Flohr, Christian
Aslan, Katrin
Mendrzyk, Regina
Schuster, Heiko
Borrelli, Marco
Valmori, Danila
Chaumette, Tanguy
Heidenreich, Regina
Gouttefangeas, Cecile
Forlani, Greta
Tagliamonte, Maria
Fusco, Caterina
Penta, Roberta
Inarrairaegui, Mercedes
Gnad-Vogt, Ulrike
Reinhardt, Carsten
Weinschenk, Toni
Accolla, Roberto S.
Singh-Jasuja, Harpreet
Rammensee, Hans-Georg
Buonaguro, Luigi
CLINICAL CANCER RESEARCH, 2022, 28 (12) : 2555 - 2566
[8] Results of the therapetuic cancer vaccine HepaVac-101 clinical trial in HCC patients
Loeffler, Markus
Izzo, Francesco
Gori, Stefania
Mayer, Andrea
Konigsrainer, Alfred
Ma, Yuk Ting
Sangro, Bruno
Francque, Sven
Accolla, Roberto
Vonghia, Luisa
Avallone, Antonio
Ludwig, Joerg
Alcoba, Diego
Aslan, Katrin
Mendrzyk, Regina
Schuster, Heiko
Borrelli, Marco
Valmori, Danila
Chaumette, Tanguy
Heidenreich, Regina
Gouttefangeas, Cecile
Forlani, Greta
Tagliamonte, Maria
Inarrairaegui, Mercedes
Gnad-Vogt, Ulrike
Reinhardt, Carsten
Weinschenk, Toni
Rammensee, Hans-Georg
Buonaguro, Luigi
JOURNAL OF HEPATOLOGY, 2021, 75 : S246 - S246
[9] Vaccine against toxic shock syndrome in a first-in-man clinical trial
Roetzer, Andreas
Jilma, Bernd
Eibl, Martha M.
EXPERT REVIEW OF VACCINES, 2017, 16 (02) : 81 - 83
[10] An arginase1-and PD-L1-derived peptide-based vaccine for myeloproliferative neoplasms: A first-in-man clinical trial
Grauslund, Jacob Handlos
Holmstrom, Morten Orebo
Martinenaite, Evelina
Lisle, Thomas Landkildehus
Glockner, Hannah Jorinde
El Fassi, Daniel
Klausen, Uffe
Mortensen, Rasmus E. J.
Jorgensen, Nicolai
Kjaer, Lasse
Skov, Vibe
Svane, Inge Marie
Hasselbalch, Hans Carl
Andersen, Mads Hald
FRONTIERS IN IMMUNOLOGY, 2023, 14

← 1 2 3 →